1. ALLA AKTIER
  2. NYHETER
  3. BRAINCOOL

BrainCool

Nyheter BrainCool Nyheter alla bolag
Affiliate
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.

BrainCool AB (publ): Publication of the quarterly report for Q1 will be brought forward to today, April 15, 2024

MARKN.

The publication of BrainCool AB’s quarterly report for Q1 2024 will be brought forward to today, April 15, 2024. The previously announced date for publication was May 2, 2024. The reason why the publication of the quarterly report is brought forward is that the report has been finalized earlier as part of the preparations for the planned financing that was announced on March 24, 2024.

Contact
For more information
Jon Berg - CEO
+46 722 50 91 19
E-mail: jon.berg@braincool.se

About Us
BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on Nasdaq First North Growth Market, named “BRAIN”.
Eminova Fondkommission AB is the company’s Certified Adviser.

Attachments
BrainCool AB (publ): Publication of the quarterly report for Q1 will be brought forward to today, April 15, 2024

Datum 2024-04-15, kl 17:54
Källa MFN
Bifogade filer
BrainCool AB (publ): Publication of the quarterly report for Q1 will be brought forward to today, April 15, 2024